Treatment of cutaneous and mucosal telangiectases in hereditary hemorrhagic telangiectasia: Report of three cases

References

• Swanson D. L., Dahl M. V. Embolic abscesses in hereditary hemorrhagic telangiectasia. J Am Acad Dermatol 1991; 24: 580–3
   Google Scholar
• Folz B. J., Lippert B. M., Wollstein A. C., Tennie J., Happle R., Werner J. A. Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia. Analysis of distribution and symptoms. Eur J Dermatol 2004; 14: 407–11
   Google Scholar
• Begbie M. E., Wallace G. M., Shovlin C. L. Hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu syndrome): A view from the 21st century. Postgrad Med J 2003; 79: 18–24
   PubMed Web of Science ®Google Scholar
• Morales Angulo C., Megia Lopez R., del Valle Zapico A., Mazon Gutierrez A., Garcia Mantilla J., Rama Quintela J. J. Rendu–Osler–Weber disease (hereditary hemorrhagic telangiectasia). Report of 30 cases. Acta Otorrinolaringol Esp 1997; 48: 625–9
   Google Scholar
• Gallitelli M., Pasculli G., Fiore T., Carella A., Sabba C. Emergencies in hereditary haemorrhagic telangiectasia. Q J Med 2006; 99: 15–22
   Google Scholar
• Dakeishi M., Shioya T., Wada Y., Shindo T., Otaka K., Manabe M., et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002; 19: 140–8
   PubMed Web of Science ®Google Scholar
• Guttmacher A. E., Marchuk D. A., White R. I., Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333: 918–24
   PubMed Web of Science ®Google Scholar
• Shovlin C. L., Hughes J. M. B., Tuddenham E. G. D., Temperley I., Perembelon Y. F. N., Scott J., et al. A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q33. Nat Genet 1994; 6: 205–9
   Google Scholar
• McDonald M. T., Papenberg K. A., Ghosh S., Glatfelter A., Biesecker B. B., Helmbold E. A., et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33–q34. Nat Genet 1994; 6: 197–204
   Google Scholar
• McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., et al. Endoglin, a TGF‐beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8: 345–51
   PubMed Web of Science ®Google Scholar
• Gallione C. J., Scheessele E. A., Reinhardt D., Duits A. J., Berg J. N., Westermann C. J. J., et al. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: Evidence for a founder effect. Hum Genet 2000; 107: 40–4
   Google Scholar
• Vincent P., Plauchu H., Hazan J., Faure S., Weissenbach J., Godet J. A third locus for hereditary haemorrhagictelangiectasia maps to chromosome 12q. Hum Mol Genet 1995; 4: 945–9
   Google Scholar
• Johnson D. W., Berg J. N., Gallione C. J., McAllister K. A., Warner J. P., Helmbold E. A., et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. PCR Methods Appl 1995; 5: 21–8
   Google Scholar
• Johnson D. W., Berg J. N., Baldwin M. A., Gallione C. J., Marondel I., Yoon S. J., et al. Mutations in the activin receptor‐like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996; 13: 189–95
   PubMed Web of Science ®Google Scholar
• McAllister K. A., Lennon F., Bowles‐Biesecker B., McKinnon W. C., Helmbold E. A., Markel D. S., et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia: Possible correlation with clinical phenotype. J Med Genet 1994; 31: 927–32
   PubMedGoogle Scholar
• Heutink P., Haitjema T., Breedveld G. J., Janssen B., Sandkuijl L. A., Botenkoe C. J. M., et al. Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 1994; 31: 933–6
   Google Scholar
• Berg J. N., Guttmacher A. E., Marchuk D. A., Porteous M. E. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin?. J Med Genet 1996; 33: 256–7
   PubMed Web of Science ®Google Scholar
• Haitjema T., Westermann C. J., Overtoom T. T., Timmer R., Disch F., Mauser H., et al. Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu disease): New insights in pathogenesis, complications, and treatment. Arch Intern Med 1996; 156: 714–19
   Google Scholar
• Gallione C. J., Repetto G. M., Legius E., Rustgi A. K., Schelley S. L., Tejpar S., et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363: 852–9
   PubMed Web of Science ®Google Scholar
• Urushihara M., Furukawa S., Ota A., Iwai A., Matsumura K., Hamada Y. Hemorrhagic telangiectasia with thrombocytopenia in a newborn infant. Pediatr Int 2000; 42: 693–5
   PubMed Web of Science ®Google Scholar
• Jacobson B. S. Hereditary hemorrhagic telangiectasia. A model for blood vessel growth and enlargement. Am J Pathol 2000; 156: 737–42
   Google Scholar
• Harries P. G., Brockbank M. J., Shakespeare P. G., Carruth J. A. S. Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser. J Laryngol Otol 1997; 111: 1038–41
   Google Scholar
• Poblete‐Gutiérrez P., Rübben A., Merk H. F., Frank J. Unilateral facial telangiectases suggest type 1 segmental manifestation of Osler–Rendu–Weber syndrome in an 11‐year‐old boy. Eur J Dermatol 2003; 13: 537–9
   Google Scholar
• Ben‐Bassat M., Kaplan M. B., Levy R. Treatment of hereditary hemorrhagic telangiectasias of the nasal mucosa with the carbon dioxide laser. Br J Plast Surg 1978; 31: 157–8
   PubMedGoogle Scholar
• Parkin J. L., Dixon J. A. Laser photocoagulation in hereditary hemorrhagic telangiectasias. Otolaryngol Head Neck Surg 1981; 89: 204–8
   Google Scholar
• Shapsay S. M., Oliver P. Treatment of hereditary hemorrhagic telangiectasias by Nd‐YAG laser photocoagulation. Laryngoscope 1984; 94: 1554–6
   Google Scholar
• Werner J. A., Lippert B. M., Geisthoff U. W., Rudert H. [Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasias.]. Laryngorhinootologie 1997; 76: 495–501
   Google Scholar
• Apfelberg D. B., Maser M. R., Lash H., Flores J. Expanded role of the argon laser in plastic surgery. J Dermatol Surg Oncol 1983; 9: 145–51
   PubMedGoogle Scholar
• Haye R., Austad J. Hereditary hemorrhagic teleangiectasia – argon laser. Rhinology 1991; 29: 5–9
   Google Scholar
• Vickery C. L., Kuhn F. A. Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 1996; 89: 78–80
   Google Scholar
• Ducic Y., Brownrigg P., Laughlin S. Treatment of haemorrhagic telangiectasia with the flashlamp‐pulsed dye laser. J Otolaryngol 1995; 24: 299–302
   Google Scholar
• Harries P. G., Brockbank M. J., Shakespeare P. G., Carruth J. A. Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser. J Laryngol Otol 1997; 111: 1038–41
   Google Scholar
• Ramirez B., Morais D., Condado M. A., Marcos M., Martín G., Poncela M. [A new sclerosant for the treatment of Rendu–Osler–Weber disease.]. Acta Otorrinolaringol Esp 2000; 51: 36–9
   Google Scholar
• Morais D., Ramírez B., Santos J. [Local sclerosant treatment with etoxiesclerol in ENT pathologies: Rendu–Osler–Weber disease, granulomas, angiomas.]. Acta Otorrinolaringol Esp 2002; 53: 658–61
   Google Scholar
• Raulin C., Weiss R. A., Schonermark M. P. Treatment of essential telangiectasias with an intense pulsed light source (PhotoDerm VL). Dermatol Surg 1997; 23: 941–5
   PubMed Web of Science ®Google Scholar
• Raulin C., Greve B., Grema H. IPL technology: A review. Lasers Surg Med 2003; 32: 78–87
   PubMed Web of Science ®Google Scholar
• Ruiz‐Esparza J., Goldman M. P., Fitzpatrick R. E., Lowe N. J., Behr K. L. Flash lamp‐pumped dye laser treatment of telangiectasia. J Dermatol Surg Oncol 1993; 19: 1000–3
   PubMedGoogle Scholar
• Gambichler T., Avermaete A., Wilmert M., Altmeyer P., Hoffmann K. Generalized essential telangiectasia successfully treated with high‐energy, long‐pulse, frequency‐doubled Nd:YAG laser. Dermatol Surg 2001; 27: 355–7
   Google Scholar
• Purcell E., Condon C. Intense pulsed light therapy in the management of hereditary benign telangiectasia. Br J Plast Surg 2004; 57: 453–5
   Google Scholar
• Grenz H., Peschen M., Wiek K., Schopf E., Vanscheidt W. Hereditary benign telangiectasia: A rare form of primary telangiectasia with successful treatment with flash‐lamp‐pumped pulsed dye laser. Vasa 1998; 27: 192–5
   Google Scholar
• Clementoni M. T., Gilardino P., Muti G. F., Signorini M., Pistorale A., Morselli P. G., et al. Facial teleangectasias: Our experience in treatment with IPL. Lasers Surg Med 2005; 37: 9–13
   PubMedGoogle Scholar
• Bjerring P., Christiansen K., Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther 2001; 3: 169–73
   PubMedGoogle Scholar
• Angermeier M. C. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther 1999; 1: 95–100
   PubMedGoogle Scholar
• Schroeter C. A., Neumann H. A. An intense light source. The photoderm VL‐flashlamp as a new treatment possibility for vascular skin lesions. Dermatol Surg 1998; 24: 743–8
   Google Scholar
• Smit J. M., Bauland C. G., Wijnberg D. S., Spauwen P. H. Pulsed dye laser treatment, a review of indications and outcome based on published trials. Br J Plast Surg 2005; 58: 981–7
   Google Scholar
• Goldman M. P. Optimal management of facial telangiectasia. Am J Clin Dermatol 2004; 5: 423–34
   Google Scholar
• Clark C., Cameron H., Moseley H., Ferguson J., Ibbotson S. H. Treatment of superficial cutaneous vascular lesions: Experience with the KTP 532 nm laser. Lasers Med Sci 2004; 19: 1–5
   PubMed Web of Science ®Google Scholar
• Alam M., Dover J. S., Arndt K. A. Treatment of facial telangiectasia with variable‐pulse high‐fluence pulsed‐dye laser: Comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg 2003; 29: 681–4
   PubMed Web of Science ®Google Scholar
• Adrian R. M., Tanghetti E. A. Long pulse 532‐nm laser treatment of facial telangiectasia. Dermatol Surg 1998; 24: 71–4
   PubMedGoogle Scholar
• McCoy S. E. Copper bromide laser treatment of facial telangiectasia: Results of patients treated over five years. Lasers Surg Med 1997; 21: 329–40
   PubMed Web of Science ®Google Scholar
• McCoy S., Hanna M., Anderson P., McLennan G., Repacholi M. An evaluation of the copper‐bromide laser for treating telangiectasia. Dermatol Surg 1996; 22: 551–7
   Google Scholar
• Levine V. J., Geronemus R. G. Adverse effects associated with the 577‐ and 585‐nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients. J Am Acad Dermatol 1995; 32: 613–17
   Google Scholar
• Garden J. M., Bakus A. D. Clinical efficacy of the pulsed dye laser in the treatment of vascular lesions. J Dermatol Surg Oncol 1993; 19: 321–6
   Google Scholar
• Neumann R. A., Leonhartsberger H., Bohler‐Sommeregger K., Knobler R., Kokoschka E. M., Honigsmann H. Results and tissue healing after copper‐vapour laser (at 578 nm) treatment of port wine stains and facial telangiectasias. Br J Dermatol 1993; 128: 306–12
   Google Scholar
• Rosenfeld H., Sherman R. Treatment of cutaneous and deep vascular lesions with the Nd:YAG laser. Lasers Surg Med 1986; 6: 20–3; 50–1
   PubMed Web of Science ®Google Scholar
• Craig R. D., Purser J. M., Lessells A. M., Hufton A. P. Argon laser therapy for cutaneous lesions. Br J Plast Surg 1985; 38: 148–55
   Google Scholar
• Apfelberg D. B., Maser M. R., Lash H., Rivers J. The argon laser for cutaneous lesions. JAMA 1981; 245: 2073–5
   PubMed Web of Science ®Google Scholar
• Apfelberg D. B., Maser M. R., Lash H. Extended clinical use of the argon laser for cutaneous lesions. Arch Dermatol 1979; 115: 719–21
   Google Scholar
• Apfelberg D. B., Maser M. R., Lash H. Argon laser management of cutaneous vascular deformities. A preliminary report. West J Med 1976; 124: 99–101
   PubMedGoogle Scholar
• Ellis D. L. Treatment of telangiectasia macularis eruptiva perstans with the 585‐nm flashlamp‐pumped dye laser. Dermatol Surg 1996; 22: 33–7
   Google Scholar
• Dave R. U., Mahaffey P. J., Monk B. E. Cutaneous lesions in hereditary haemorrhagic telangiectasia: Successful treatment with the tunable dye laser. J Cutan Laser Ther 2000; 2: 191–3
   PubMedGoogle Scholar
• Lyons G. D., Owens R. E., Mouney D. F. Argon laser destruction of cutaneous telangiectatic lesions. Laryngoscope 1981; 91: 1322–5
   Google Scholar